Insider Stock Trading History of Grey Michael G


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Grey Michael G since year 2005. The trader's CIK number is 1240122. At the time of this reporting, Grey Michael G is the Director of Horizon Pharma, Inc. . (stock ticker symbol HZNP). See this page for all insider trading activities at Horizon Pharma, Inc. .

Note that in the past GREY MICHAEL G also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Grey Michael G since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-10 HZNP Horizon Pharma, Inc. Buy 10,000 9.48 94,800
2017-05-03 HZNP Horizon Pharma, Inc. Option Ex 13,953 .00 0
2016-02-22 BMRN Biomarin Pharmaceutical Inc Option Ex 7,500 38.59 289,425
2016-02-22 BMRN Biomarin Pharmaceutical Inc Sale 7,500 80.00 600,000
2015-11-16 BMRN Biomarin Pharmaceutical Inc Option Ex 7,500 38.59 289,425
2015-11-16 BMRN Biomarin Pharmaceutical Inc Sale 7,500 104.27 782,055
2013-12-11 BMRN Biomarin Pharmaceutical Inc Option Ex 30,000 21.78 653,310
2013-12-11 BMRN Biomarin Pharmaceutical Inc Sale 30,000 69.66 2,089,680
2013-03-06 BMRN Biomarin Pharmaceutical Inc Sale 15,000 60.61 909,135
2013-03-03 BMRN Biomarin Pharmaceutical Inc Option Ex 15,000 14.39 215,850
2012-02-23 BMRN Biomarin Pharmaceutical Inc Option Ex 30,000 16.92 507,600
2008-03-05 BMRN Biomarin Pharmaceutical Inc Sale 3,500 38.42 134,470
2008-03-05 BMRN Biomarin Pharmaceutical Inc Option Ex 30,000 10.33 309,900
2008-03-05 BMRN Biomarin Pharmaceutical Inc Sale 21,500 38.19 821,085

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grey Michael G (Director of Horizon Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.